A Network Inference Method for Large-Scale Unsupervised Identification of Novel Drug-Drug Interactions

PLoS Computational Biology

Volumn 9, Issue 12, 2013, Pages

  Guimerà, Roger ^a,b   Sales Pardo, Marta ^b  

^a INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFERENCE ENGINES;

BIOCHEMICAL INFORMATION; DRUG-DRUG INTERACTIONS; INFERENCE ALGORITHM; INFERENCE METHODS; INPUT SET; LARGE-SCALE DATABASE; LARGE-SCALES; MECHANISM OF ACTION; NETWORK INFERENCE; PAIRWISE INTERACTION;

DRUG INTERACTIONS;

ACETOPHENAZINE; BROMOCRIPTINE; CINACALCET; CISAPRIDE; CLARITHROMYCIN; DEXFENFLURAMINE; DONEPEZIL; ERYTHROMYCIN; FLUCONAZOLE; GALANTAMINE; GUANETHIDINE; ITRACONAZOLE; KETOCONAZOLE; PHENTERMINE; PHENYLPROPANOLAMINE; PROTRIPTYLINE; RITONAVIR; RIVASTIGMINE; TACRINE; TACROLIMUS; TELITHROMYCIN; TERFENADINE; TRAMADOL; TRAZODONE; TRIMETHOBENZAMIDE; TRIMIPRAMINE; TRIPROLIDINE; TROSPIUM CHLORIDE; UNINDEXED DRUG; VORICONAZOLE;

ALGORITHM; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; DRUG INTERACTION; DRUG MECHANISM; DRUG TARGETING; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE;

ALGORITHMS; DATABASE MANAGEMENT SYSTEMS; DRUG DISCOVERY; DRUG INTERACTIONS; MODELS, THEORETICAL;

EID: 84892778654     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003374     Document Type: Article

References (40)

1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, et al. (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300: 2867-2878.
2. Zhang L, Zhang YD, Zhao P, Huang SM, (2009) Predicting drug-drug interactions: an FDA perspective. AAPS J 11: 300-306.
3. Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen LM, et al. (2009) Synergistic drug combi-nations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27: 659-666.
4. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R, (2009) Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7: 460-466.
5. Chait R, Craney A, Kishony R, (2007) Antibiotic interactions that select against resistance. Nature 446: 668-671.
6. Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK, (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2: 458-466.
7. Hopkins AL, (2008) Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
8. Berger S, Iyengar R, (2009) Network analyses in systems pharmacology. Bioinformatics 25: 2466-2472.
9. Jia J, Zhu F, Ma X, Cao Z, Li Y, et al. (2009) Mechanisms of drug combinations: Interaction and network perspectives. Nat Rev Drug Discov 8: 111-128.
10. Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M, (2011) Network-based analysis and characterization of adverse drug-drug interactions. J Chem Inf Model 51: 2977-2985.
11. Barabási AL, Gulbahce N, Loscalzo J, (2011) Network medicine: A network-based approach to human disease. Nat Rev Genet 12: 58-68.
12. Guimerà R, Amaral LAN, (2005) Functional cartography of complex metabolic networks. Nature 433: 895-900.
13. Guimerà R, Sales-Pardo M, Amaral L, (2007) A network-based method for target selection in metabolic networks. Bioinformatics 23: 1616-1622.
14. Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, et al. (2011) Predicting selective drug targets in cancer through metabolic networks. Molecular Systems Biology 7: 501.
15. Zhao X, Iskar M, Zeller G, Kuhn M, van Noort V, et al. (2011) Prediction of drug combinations by integrating molecular and pharmacological data. PLoS Comput Biol 7: e1002323.
16. Wood K, Nishida S, Sontag ED, Cluzel P, (2012) Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci USA 109: 12254-12259.
17. Amaral LAN, Ottino JM, (2004) Complex networks: Augmenting the framework for the study of complex systems. Eur Phys J B 38: 147-162.
18. Newman MEJ (2010) Networks: An Introduction. 1st edition. USA: Oxford University Press.
19. Guimerà R, Sales-Pardo M, (2009) Missing and spurious interactions and the reconstruction of complex networks. Proc Natl Acad Sci U S A 106: 22073-22078.
20. Yeh P, Tschumi AI, Kishony R, (2006) Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38: 489-494.
21. Lehár J, Zimmermann GR, Krueger AS, Molnar RA, Ledell JT, et al. (2007) Chemical combination effects predict connectivity in biological systems. Mol Syst Biol 3: 80.
22. Yeh P, Kishony R, (2007) Networks from drug-drug surfaces. Mol Syst Biol 3: 85.
23. White HC, Boorman SA, Breiger RL, (1976) Social structure from multiple networks. i. blockmodels of roles and positions. Am J Sociol 81: 730-780.
24. Holland PW, Laskey KB, Leinhardt S, (1983) Stochastic blockmodels: First steps. Soc Networks 5: 109-137.
25. Nowicki K, Snijders TAB, (2001) Estimation and prediction for stochastic blockstructures. J Am Stat Assoc 96: 1077-1087.
26. Newman MEJ, (2011) Communities, modules and large-scale structure in networks. Nat Phys 8: 25-31.
27. Segrè D, Deluna A, Church GM, Kishony R, (2005) Modular epistasis in yeast metabolism. Nat Genet 37: 77-83.
28. Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, et al. (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7: 544.
29. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) Drugbank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901-D906.
30. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) Drugbank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-D1041.
31. Hanley J, McNeil B, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
32. Tatonetti N, Patrick P, Daneshjou R, Altman R, (2012) Data-driven prediction of drug effects and interactions. Sci Transl Med 4: 125ra31-125ra31.
33. Cami A, Arnold A, Manzi S, Reis B, (2011) Predicting adverse drug events using pharmacological network models. Sci Transl Med 3: 114ra127.
34. Yildirim M, Goh K, Cusick M, Barabási A, Vidal M, et al. (2007) Drug-target network. Nat Biotechnol 25: 1119.
35. Colinge J, Rix U, Bennett K, Superti-Furga G, (2011) Systems biology analysis of protein-drug interactions. Prot Clin Appl 6: 102-116.
36. Zhao S, Li S, (2012) A co-module approach for elucidating drug-disease associations and revealing their molecular basis. Bioinformatics 28: 955-961.
37. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci U S A 104: 8685-8690.
38. Guimerà R, Sales-Pardo M, (2012) Predicting human preferences using the block structure of complex social networks. PLoS One 7: e44620.
39. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E, (1953) Equation of state calculations by fast computing machines. J Chem Phys 21: 1087-1092.
40. Sales-Pardo M, Guimerà R, Moreira AA, Amaral LAN, (2007) Extracting the hierarchical organization of complex systems. Proc Natl Acad Sci U S A 104: 15224-15229.